Yizhen Fu

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 10

Top Topics

Peritoneal Dialysis

Prognostic Factors

Radiofrequency Ablation

Top Venues

Journal of hepatocellular carcinoma

Journal of oncology

Journal of inflammation research

This page only lists publications with an associated author ORCID identifier.

Publications

Zhenyun Yang, Zi-Li Hu, Yizhen Fu, Dandan Hu, Zhongguo Zhou, Minshan Chen, Yang-Xun Pan, Yao-Jun Zhang
Laparoscopic Hepatectomy versus Open Hepatectomy After Conversion Therapy Using Transarterial Chemoembolization or Hepatic Arterial Infusion Chemotherapy for Patients with Initially Unresectable Hepatocellular Carcinoma. Journal of hepatocellular carcinoma 10 (2023)
Yizhen Fu, Xia Li, Zhenyun Yang, Shaoqiang Li, Yang-Xun Pan, Jin-Bin Chen, Juncheng Wang, Dandan Hu, Zhong-Guo Zhou, Li Xu, Minshan Chen, Yao-Jun Zhang
A risk-based postresection follow-up strategy for hepatocellular carcinoma patients. Cancer 129 (4) (2022)
Zhenyun Yang, Deyao Zhang, Huilan Zeng, Yizhen Fu, Zi-Li Hu, Yang-Xun Pan, Jin-Bin Chen, Juncheng Wang, Yao-Jun Zhang, Zhongguo Zhou, Li Xu, Dandan Hu, Minshan Chen
Inflammation-Based Scores Predict Responses to PD-1 Inhibitor Treatment in Intrahepatic Cholangiocarcinoma. Journal of inflammation research 15 (2022)
Yizhen Fu, Xia Li, Zhenyun Yang, Shaoqiang Li, Yang-Xun Pan, Jin-Bin Chen, Juncheng Wang, Dandan Hu, Zhong-Guo Zhou, Li Xu, Minshan Chen, Yao-Jun Zhang
A risk-based postresection follow-up strategy for hepatocellular carcinoma patients. Cancer 129 (4) (2022)
Yizhen Fu, Xia Li, Zhenyun Yang, Shaoqiang Li, Yang-Xun Pan, Jin-Bin Chen, Juncheng Wang, Dandan Hu, Zhong-Guo Zhou, Li Xu, Minshan Chen, Yao-Jun Zhang
A risk-based post-resection follow-up strategy for hepatocellular carcinoma patients. Cancer (2022)
Zi-Li Hu, Yu Yuan, Zhiwen Hu, Qingbo Liu, Yizhen Fu, Jingyu Hou, Xuqi Sun, Shaoqiang Li, Wenbin Duan, Minshan Chen
Development and Validation of Prognostic Nomograms for Hepatocellular Carcinoma After Hepatectomy Based on Inflammatory Markers. Journal of hepatocellular carcinoma 9 (2022)
Zi-Li Hu, Yu Yuan, Zhiwen Hu, Qingbo Liu, Yizhen Fu, Jingyu Hou, Xuqi Sun, Shaoqiang Li, Wenbin Duan, Minshan Chen
Development and Validation of Prognostic Nomograms for Hepatocellular Carcinoma After Hepatectomy Based on Inflammatory Markers. Journal of hepatocellular carcinoma 9 (2022)
Yizhen Fu, Xia Li, Zhenyun Yang, Shaoqiang Li, Yang-Xun Pan, Jin-Bin Chen, Juncheng Wang, Dandan Hu, Zhong-Guo Zhou, Li Xu, Minshan Chen, Yao-Jun Zhang
A risk-based postresection follow-up strategy for hepatocellular carcinoma patients. Cancer 129 (4) (2022)
Zi-Li Hu, Xuqi Sun, Jie Mei, Zhiwen Hu, Ziliang Yang, Jingyu Hou, Yizhen Fu, Xiao-Hui Wang, Minshan Chen
Antiviral Treatments Eliminate the Adverse Impacts of High Baseline HBV Loads on the Survival of HBV-Related HCC Patients. Journal of hepatocellular carcinoma 9 (2022)
Yizhen Fu, Mian Xi, Yangxun Pan, Jinbin Chen, Juncheng Wang, Shiliang Liu, Li Xu, Zhong-Guo Zhou, Mengzhong Liu, Minshan Chen, Lei Zhao, Yao-Jun Zhang
Stereotactic Body Radiotherapy as a Salvage Therapy after Incomplete Radiofrequency Ablation for Hepatocellular Carcinoma: A Retrospective Cohort Study. Journal of oncology 2020 (2020)